Skip to main content

Table 1 Characteristics of ovarian cancer patients and control groups: benign ovarian tumor and healthy subjects

From: Plasma levels of MMP-7 and TIMP-1 in laboratory diagnostics and differentiation of selected histological types of epithelial ovarian cancers

Study group Number of patients
Epithelial ovarian cancer patients 100 (100%)
 • median age (range) 59 (46–87)
  - sub-type serous epithelial 54 (54%)
 • median age (range) 59 (46–81)
  - sub-type endometrioid epithelial 46 (46%)
 • median age (range) 59 (49–87)
Tumor stage IA-T1aN0M0 5 (5%)
IB-T1bN0M0 7 (7%)
IC-T1cN0M0 13 (13%)
IIA-T2aN0M0 8 (8%)
IIB-T2bN0M0 9 (9%)
IIC-T2cN0M0 8 (8%)
IIIA-T3aN0M0 9 (9%)
IIIB-T3bN0M0 9 (9%)
IIIC-T3cN0M0 7 (7%)
IV(metastases) 25 (25%)
Menopausal status:
- postmenopausal 100 (100%)
Benign ovarian tumor patients 80 (100%)
 - type cystis serous 40 (50%)
 - type cystis endometriosis 40 (50%)
Median age (range) 54 (48–68)
Menopausal status:
 - postmenopausal 80 (100%)
Healthy subjects 80 (100%)
Median age (range) 55 (47–64)
Menopausal status:
 - postmenopausal 80 (100%)